Researchers have applied AI to every step of the drug development process. But this might not be enough to design safe and ...

Tevogen Bio Holdings Inc. (“Company” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T-cell therapeutics for ...

New documents clarify how the FDA plans to regulate AI-enabled devices, experts say, but several important questions remain ...

Doctors have an overwhelming amount of individual patient data and medical research at their disposal to make diagnoses and ...

The Food and Drug Administration (FDA) has recently released two draft guidance documents (Artificial Intelligence-Enabled Device Software ...

Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop ...

Kanavos Inc. has announced a strategic partnership with Graphwise, a global leader in semantic AI technologies, and HomeLab, a prominent biotech accelerator based at UC San Diego, to develop the ...

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...

As marketers leverage AI to develop images, understanding how to do so ... what most people know as our ‘stock’ library—and include indemnification and perpetual, worldwide usage rights ...

The initiative will build and power the infrastructure required to digitize and deliver impactful AI-driven pathology solutions to patients and caregivers.